Jefferies initiates coverage on Chime Financial stock with Hold rating

Investing.comMonday, November 3, 2025 at 7:47:49 AM
Jefferies initiates coverage on Chime Financial stock with Hold rating
Jefferies has started coverage on Chime Financial's stock, assigning it a Hold rating. This move is significant as it reflects the investment firm's cautious approach towards Chime's market performance. Investors may want to pay attention to this rating as it could influence trading decisions and market perceptions of Chime Financial's future.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Jefferies reiterates Hold rating on Skyward Specialty Insurance stock with $52 price target
NeutralFinancial Markets
Jefferies has maintained a Hold rating on Skyward Specialty Insurance, setting a price target of $52 for the stock. This decision reflects a cautious outlook on the company's performance, suggesting that while there may be potential for growth, investors should approach with care. Understanding these ratings helps investors make informed decisions about their portfolios.
Jefferies lowers DTE Energy stock price target to $149 on growth outlook
NegativeFinancial Markets
Jefferies has lowered its price target for DTE Energy's stock to $149, reflecting concerns about the company's growth outlook. This adjustment is significant as it indicates a lack of confidence in DTE Energy's future performance, which could impact investor sentiment and stock value. Investors should pay attention to these changes as they may influence market trends and investment decisions.
Jefferies initiates DT Midstream stock with Buy rating on data center growth
PositiveFinancial Markets
Jefferies has initiated coverage of DT Midstream with a Buy rating, highlighting the company's potential for growth driven by the increasing demand for data centers. This is significant as it reflects investor confidence in DT Midstream's ability to capitalize on the booming data center market, which is crucial for the future of technology and connectivity.
TechnipFMC price target raised to $50 from $47 at Jefferies on shareholder returns
PositiveFinancial Markets
Jefferies has raised its price target for TechnipFMC from $47 to $50, highlighting the company's strong potential for shareholder returns. This adjustment reflects confidence in TechnipFMC's financial performance and growth strategy, which is crucial for investors looking for promising opportunities in the energy sector.
Cigna price target lowered to $310 from $336 at Jefferies on PBM model transition
NegativeFinancial Markets
Cigna's price target has been reduced from $336 to $310 by Jefferies, reflecting concerns over the company's transition to a new pharmacy benefit management (PBM) model. This adjustment is significant as it indicates potential challenges ahead for Cigna, which could impact investor confidence and the company's market performance. Understanding these changes is crucial for stakeholders as they navigate the evolving landscape of healthcare management.
Jefferies downgrades Maruti Suzuki stock to Hold after 49% rally
NegativeFinancial Markets
Jefferies has downgraded Maruti Suzuki's stock to 'Hold' following a significant 49% rally in its share price. This decision reflects concerns about the sustainability of the stock's recent gains and suggests that investors should be cautious moving forward. The downgrade is important as it may influence investor sentiment and market dynamics, especially in the automotive sector.
Bank of Baroda price target raised to INR295 from INR255 at Jefferies
PositiveFinancial Markets
Jefferies has raised its price target for Bank of Baroda from INR 255 to INR 295, reflecting a positive outlook on the bank's performance. This adjustment indicates confidence in the bank's growth potential and could attract more investors, highlighting the bank's strong fundamentals and market position.
Latest from Financial Markets
Estrella Immunopharma stock soars after 100% complete response rate in trial
PositiveFinancial Markets
Estrella Immunopharma's stock has seen a remarkable surge following the announcement of a 100% complete response rate in its latest clinical trial. This impressive result not only boosts investor confidence but also highlights the potential of Estrella's treatments in the healthcare market. Such positive outcomes can lead to increased funding and further research opportunities, making it a significant development for both the company and its stakeholders.
Kimberly-Clark to Buy Tylenol Maker Kenvue for $40 Billion
PositiveFinancial Markets
In a significant move, Kimberly-Clark has announced its intention to acquire Kenvue, the maker of Tylenol, for a staggering $40 billion. This acquisition is poised to strengthen Kimberly-Clark's portfolio in the consumer health sector, allowing them to expand their reach and enhance their product offerings. The deal highlights the growing trend of consolidation in the healthcare industry, as companies seek to leverage synergies and improve their competitive edge.
Auna stock falls after tender offer for senior notes
NegativeFinancial Markets
Auna's stock has taken a hit following its recent tender offer for senior notes, raising concerns among investors. This move, while aimed at managing debt, has led to a decline in market confidence, reflecting the challenges the company faces in maintaining its financial stability. Understanding the implications of such financial maneuvers is crucial for stakeholders as they navigate the complexities of the stock market.
DuPont Spinoff Qnity Jumps On First Day of Trading; Will Join S&P 500 After Public Debut
PositiveFinancial Markets
DuPont's spinoff, Qnity, made a strong debut on its first day of trading, reflecting optimism in the market, particularly with the ongoing AI boom. This positive performance is significant as Qnity is set to join the S&P 500, which could further enhance its visibility and attract more investors. The success of Qnity not only highlights the potential of new companies emerging from established firms but also underscores the growing influence of AI in shaping market trends.
Dollar edges up as rate cut outlook remains clouded
NeutralFinancial Markets
The dollar has seen a slight increase as uncertainty looms over the outlook for interest rate cuts. This situation is significant as it reflects the ongoing complexities in the economy and how investors are reacting to potential changes in monetary policy. The fluctuations in the dollar's value can impact global markets and influence economic decisions, making it a key point of interest for both investors and policymakers.
Jon Stewart to Stay at ‘The Daily Show’ Through 2026
PositiveFinancial Markets
Jon Stewart has announced that he will continue his role at 'The Daily Show' through 2026, much to the delight of fans. Known for his incisive humor and sharp critiques, particularly of President Trump, Stewart's presence is expected to bring a fresh perspective to the show during a pivotal time in politics. His commitment to the program not only reinforces its relevance but also promises to engage audiences with thought-provoking content.